A suit filed for a trio of anti trust by Glaxo Smith Kline has been upheld by a Senior U.S. District Judge Anita B. Brody without giving importance to the arguments by GSK lawyers. The claim of the Plaintiffs is that GSK improperly influenced the Food and Drug administration’s process and set extremely rigorous requirements for the launch of cheaper generic versions of the drug Flonase by others and that is how GSK’s sales of Flonase peaked at $1.3 billion in 2005. Copies of the 31-page opinion in In re Flonase Antitrust Litigation are available from The Legal Intelligencer.
Read the original article here:
Federal Judge Refuses to Dismiss Flonase Antitrust Suits
Posted by EmploymentCrossing
on June 9, 2011. Filed under Home,Legal News.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
Attorney Career Resources is sponsored by BCG Attorney Search, the nation's leading placement firm, specializing in law firm placements.
Law firms of all sizes are being much more selective about who makes equity partner. Gone are the days where doing good work and putting in your time is enough to get you to a profit sharing level. Today, equity partners almost always have to prove that they can contribute their share to the firm. So what does this mean for associates and how can a two-tiered partnership track be beneficial? With a two-tiered partnership structure, associates get more time to prove themselves and also more time to determine whether partnership is the right goal for them. Two-tier partnerships (non-equity and equity) exist so the firm can train and develop associates into equity partners. The non-equity track to partner at most firms is on average, 6 years long. [...]
May 16, 2013 Read More
 |
||
| Search Thousands of Legal Jobs | ||
|
Job Type: |
||
 |
||
|
Browse Jobs by Location: |
||
|
||
| Keyword Search: | ||
|
||
Recent comments